BioConvergence pour la
Santé
Domaine d’Intérêt Majeur (DIM) de la Région Île-de-France
What is Bioconvergence?
Bioconvergence is the integration of biology with other fields like engineering, physics, and data science to create innovative solutions in healthcare, biotechnology, and beyond. It involves combining the principles and tools of these disciplines to address complex biological challenges more effectively. By merging biological systems with technological advancements, bioconvergence enables breakthroughs in areas such as precision medicine, advanced therapeutics, and biofabrication. This interdisciplinary approach accelerates the development of novel diagnostics, treatments, and sustainable biomanufacturing processes, fostering a new era of innovation that leverages the strengths of diverse scientific domains.
BioConvS x Pint of Science 2025
The Atrium Humanités et Sciences Sociales, the DIM BioConvS and the Faculté des Sciences of Université Paris Cité join forces to organize events during the next edition of the Pint of Science 2025 on May 19th to 21st 2025! Do you like science and making it accessible?...
Inventor’s challenge
Register to the “Défi Inventeur et Inventrice 2025” Why To benefit from assistance in the patenting process and immersion in a culture of invention. This is an initiative designed to encourage innovation and promote a culture of invention among scientists from...
Call for Expression of Interest – POD
What is this call for expressions of Interest? The Proof-of-concept demonstrator (POD) call for expressions of interest aims to identify projects in the field of biotherapies, requiring to de-risk innovation with the support of an industrial integrator at Paris...
Our 2024 postdoc call is open
Our 2024 postdoc call, which will fund 2 postdoctoral 2-year fellowships in the field of synthetic biology for health, is open until January 30th, 2025. This call will fund fellowships for a project in collaboration between two academic research laboratories; an...
BioConvS at Medicen Day 2024
BioConvS will be present at Medicen Day on October 1st! Medicen Day 2024, une journée pour fédérer l’excellence scientifique et industrielle francilienne Le pôle de compétitivité Medicen Paris Region organise une nouvelle édition de son évènement éponyme, le...
SynBioTherapy
Join us to discuss the synergies between synthetic biology and biotherapies to shape the healthcare of the future!When: November 27th, 2024 Where: Auditorium of the Learning Planet Institute, 8bis rue Charles V 75004 ParisThis conference, co-organized by DIM BioConvS,...
Innovation Day 2024
Best poster award Congratulations to Sara Falghera for winning the Best Poster Prize of our 2024 symposium! Miniaturized asymmetrical flow field flow fractionation on a soft thermoplastic chip asymmetrical flow field flow fractionation, tangential flow filtration,...
iGEM projects 2024
For the 2024 iGEM edition, 3 iGEM teams were created in Ile-de-France. Each of them received an equal financial support from the DIM BioConvS for their project.PANCE-EVO.T7 iGEM Evry Paris-Saclay The aim of our project is to develop a powerful directed evolution tool...
iGEM projects 2023
For 2023, 4 iGEM teams were created in Ile-de-France. Each of them received an equal financial support from the DIM BioConvS for their project.OptoGen EYEsis: evolution of microbial opsins for Retinal Therapy iGEM Evry Paris-Saclay Opsins are light sensitive proteins...
What is BioConvS?
BioConvergence for Health (BioConvS) is a Domain of Major Research and Innovation (DIM) funded by the Ile de France region. It aims to structure the communities of synthetic biology, biotherapy and bioproduction to guide the transition from scientific excellence to innovation, and to position Île-de-France region as an international reference in the domain. BioConvS, led by Université Paris Cité in partnership with Sorbonne and Paris-Saclay universities, Curie Institute (PSL), Micalis Institute (INRAe), Evry Genopole cluster, APHP and INSERM groups actors from the public and private sectors and benefits from 12.5M€ support from the Ile de France Region.
Principal axes
BioConvS gathers the Île-de-France scientific community working on the following axes:
- Life sciences engineering and bioproduction
- Development of therapeutics proofs-of-principles
- New, high throughput, standardisable analythic methods
- Digital or AI tools to improve data analysis or modelling in quality control and production methods
- Guarantee an inclusive, ethical, sustainable Bioconvergence
Distributed Biofoundry
BioConvS will support a network of distributed biofounderies (with the participation of Sorbonne University, INRAe, Institut Curie, Genopole and Université Paris Cité) to make technologies for life design and engineering accessible to Île-de-France Region public and private R&D. This will include the acquisition and pooling of high-tech equipment dedicated to the molecular engineering of living systems and bioproduction to create genetic circuits, synthetic cells and bioprocesses on demand.
CollectivE Digital Intelligence Platform (DICE)
BioConvS will develop an AI-supported framework of digital resources to design, document and share BioConvS researchers’ profiles, expertise and projects in a virtual collaborative research space. This platform, open to the general public, will strengthen the capacity for exchange between DIM’s partners and society.
Consult our data protection policy
Address:
DIM BioConvS
Faculté des Sciences - Université Paris Cité
5 rue Thomas Mann 75013 Paris
